Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-12-000055
Filing Date
2012-01-13
Accepted
2012-01-13 12:37:14
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ohr-10k_093011.htm 10-K 770805
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31_1.htm EX-31.1 12245
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31_2.htm EX-31.2 10607
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32_1.htm EX-32.1 5838
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32_2.htm EX-32.2 5571
12 GRAPHIC image_004.jpg GRAPHIC 118180
  Complete submission text file 0001387131-12-000055.txt   2795234

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ohrp-20110930.xml EX-101.INS 306074
7 XBRL SCHEMA FILE ohrp-20110930.xsd EX-101.SCH 15037
8 XBRL CALCULATION FILE ohrp-20110930_cal.xml EX-101.CAL 30193
9 XBRL DEFINITION FILE ohrp-20110930_def.xml EX-101.DEF 24628
10 XBRL LABEL FILE ohrp-20110930_lab.xml EX-101.LAB 135058
11 XBRL PRESENTATION FILE ohrp-20110930_pre.xml EX-101.PRE 90726
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 133709558 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-88480 | Film No.: 12525927
SIC: 2834 Pharmaceutical Preparations